Cited by

• An autopsy case of acute porphyria with a decrease of both uroporphyrinogen I synthetase and ferrochelatase activities.

  Yamada M, Kondo M, Tanaka M, Okeda R, Hatakeyama S, Fukui T, Tsukagoshi H. Yamada M, et al. Acta Neuropathol. 1984;64(1):6-11. doi: 10.1007/BF00695599. Acta Neuropathol. 1984. PMID: 6089495
• Effects of delta-aminolaevulinic acid, porphobilinogen and structurally related amino acids on 2-deoxy-glucose uptake in cultured neurons.

  Russell VA, Lamm MC, Taljaard JJ. Russell VA, et al. Neurochem Res. 1982 Aug;7(8):1009-22. doi: 10.1007/BF00965140. Neurochem Res. 1982. PMID: 6128684
• 5-Aminolevulinic acid inhibits [3H]muscimol binding to human and rat brain synaptic membranes.

  Emanuelli T, Pagel FW, Alves LB, Regner A, Souza DO. Emanuelli T, et al. Neurochem Res. 2001 Feb;26(2):101-5. doi: 10.1023/a:1011034409814. Neurochem Res. 2001. PMID: 11478735
• Increased delta aminolevulinic acid and decreased pineal melatonin production. A common event in acute porphyria studies in the rat.

  Puy H, Deybach JC, Bogdan A, Callebert J, Baumgartner M, Voisin P, Nordmann Y, Touitou Y. Puy H, et al. J Clin Invest. 1996 Jan 1;97(1):104-10. doi: 10.1172/JCI118376. J Clin Invest. 1996. PMID: 8550820 Free PMC article.
• Pathogenesis and treatment of acute intermittent porphyria: discussion paper.

  Laiwah AC, Goldberg A, Moore MR. Laiwah AC, et al. J R Soc Med. 1983 May;76(5):386-92. doi: 10.1177/014107688307600512. J R Soc Med. 1983. PMID: 6864706 Free PMC article. No abstract available.